Multiple myeloma (MM), although relatively rare, is a highly heterogeneous cancer accounting for around 10% of all hematological malignancies. MM is the second most common blood cancer, with over 5...
Read more Investigadores de la Universidad de Stanford han desarrollado un dispositivo que permite analizar de forma simultánea el efecto de cientos de mutaciones diferentes sobre una misma enzima. La h...
Read more3P Biopharmaceuticals and Precirix NV have signed an agreement for the clinical manufacturing of a camelid single-domain antibody fragment (sdAb), the backbone of Precirix’ next product candidate to...
Read moreSeven out of ten women say they have had rule changes after vaccination, according to a preliminary survey of 14,000. Now, researchers from Granada will study their menstrual health to find out if the...
Read moreLos medicamentos de microinmunoterapia se utilizan como reguladores del sistema inmune tanto en su respuesta defensiva frente a patógenos cómo en la tolerancia hacia elementos no patógenos.
Read moreCystinuria is a rare disease characterized by the formation of cystine stones in the kidney and urinary tract.
Read moreLa enfermedad de Alzheimer sí tiene tratamiento, aunque paliativo, no curativo. En la actualidad, lamentablemente, no contamos en el mercado con ningún tratamiento efectivo que pueda modificar, dete...
Read moreIBEC researchers develop a three-dimensional model of muscle tissue using bioprinting and tissue bioengineering techniques that allow reproducing their strength, contraction and aging profiles. The ne...
Read moreResearchers from the Hospital del Mar Medical Research Institute (IMIM) have discovered a novel mechanism through which the serotonin receptor interacts with cell membranes in the human brain. This fi...
Read moreThe global market for combination products (i.e., drug-eluting stents, transdermal patches, infusion pumps, inhalers) has been unstoppably growing over the last decade.
Read moreUn grupo de investigadores de la Escuela Baylor de Medicina , la Universidad de Oxford, la Universidad de Wisconsin-Madison y la farmacéutica Bayer ha relacionado un gen, NPSR1, con el desarrollo de ...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...
Read more